Trial testing a unique formulation of ibuprofen to treat COVID-19 launches
A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS), a complication of COVID-19, has launched in south London.
By NIHR Maudsley BRC at 1 Jun 2020